Important notification
12.06.2024 To the attention of all importers, distributors and users of medical devices The NAMMDR warns all importers and distributors […]
Important notification
06.06.2024 To the attention of all Marketing Authorisation Holders / Legal representatives of Marketing Authorisation Holders Please be advised that, […]
Important notification
30.05.2024 To the attention of all importers, distributors and users of medical devices The NAMMDR warns all importers and distributors […]
Important notification
28.05.2024 To the attention of all importers, distributors and users of medical devices The NAMMDR warns all importers and distributors […]
Important notification
27.05.2024 To the attention of interested persons The Commission Implementation Decision of 24.05.2024 concerning, within the framework of Article 31 […]
Important notification
20.05.2024 To the attention of applicants and Marketing Authorisation Holders of medicinal products for human use Following the publication of […]
Press release
16.05.2024 To the attention of interested persons Hydroxyprogesterone caproate medicines to be suspended from the EU market. Medicinal products containing […]
Important notification
09.05.2024 To the attention of all importers, distributors and users of medical devices The NAMMDR warns all importers and distributors […]
Important notification
08.05.2024 To the attention of all importers, distributors and users of medical devices The NAMMDR warns all importers and distributors […]
Important notification
08.05.2024 To the attention of all importers, distributors and users of medical devices The NAMMDR warns all importers and distributors […]